The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT

NCT07162792 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease(CAD)
de Novo Coronary Lesions

Interventions

DEVICE: bioresorbable scaffold
DEVICE: drug-coated balloon

Sponsor

Xuzhou Third People's Hospital